← All organizations
Last known activity
Sep 1, 2007
Acquired by Abbott on Jan 1, 2010
Timeline
2000s
- Jan 1, 2008
Facet Biotech— Founded
- Jan 1, 2008
PDL BioPharma— Acquired
2010s
- Jan 1, 2010
Abbott— Acquired By
Drugs by trial phase (25 distinct, 29 trials)
Phase 4 (0 own, 1 via acquisition)
Phase 3 (4 own, 1 via acquisition)
Phase 2 (6 own, 8 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (0 own, 3 via acquisition)
Indications
Studied for
- Asthma
- Carcinoma, Ovarian Epithelial
- Colitis
- Colitis, Ulcerative
- Crohn Disease
- Cytomegalovirus Retinitis
- Diabetes Mellitus
- Digestive System Diseases
- Fistula
- Gastrointestinal Diseases
- Graft vs Host Disease
- Heart Failure
- Hypertension
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Peritoneal Neoplasms
- Psoriasis
- Retinitis
- Ulcer
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (24)
- NCT00528827Lead sponsorPhase 2Sep 1, 2007
- NCT00516841Lead sponsorPhase 2Aug 1, 2007
- NCT00502294Lead sponsorPhase 3Jul 13, 2007
- NCT00487799Lead sponsorPhase 1Jun 15, 2007
- NCT00425347Lead sponsorPhase 1Dec 1, 2006
- NCT00279435Lead sponsorPhase 2/Phase 3Aug 1, 2006
- NCT00279422Lead sponsorPhase 2/Phase 3Feb 1, 2006
- NCT00267709Lead sponsorPhase 2Feb 1, 2005
- NCT00267722Lead sponsorPhase 2Feb 1, 2005
- NCT00267306Lead sponsorPhase 1/Phase 2Jan 1, 2004
- NCT00073047Lead sponsorPhase 2Apr 1, 2003
- NCT00032305Lead sponsorPhase 2/Phase 3Mar 1, 2002
- NCT00032292Lead sponsorPhase 1/Phase 2Mar 1, 2002
- NCT00072943Lead sponsorPhase 2Mar 1, 2002
- NCT00032279CollaboratorPhase 2Mar 1, 2002
Details
- Founded
- Redwood City, CA, US Jan 1, 2008
- Last known activity
- Sep 1, 2007